Details for Patent: 8,962,572
✉ Email this page to a colleague
Which drugs does patent 8,962,572 protect, and when does it expire?
Patent 8,962,572 protects BORTEZOMIB and is included in one NDA.
This patent has four patent family members in four countries.
Summary for Patent: 8,962,572
Title: | Bortezomib formulations |
Abstract: | A bortezomib composition includes bortezomib and boric acid in a mass ratio of boric acid to bortezomib is from 1:1 to 10:1. The composition is a solid, and may be prepared by forming a liquid mixture including a solvent, bortezomib and boric acid, and lyophilizing the liquid mixture. |
Inventor(s): | Usayapant; Arunya (Mundelein, IL), Bowman; David (Mattawan, MI) |
Assignee: | Fresenius Kabi USA, LLC (Lake Zurich, IL) |
Application Number: | 13/252,421 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 8,962,572
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fresenius Kabi Usa | BORTEZOMIB | bortezomib | POWDER;INTRAVENOUS | 205004-001 | Nov 6, 2017 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,962,572
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2011312264 | ⤷ Try a Trial | |||
Canada | 2813003 | ⤷ Try a Trial | |||
European Patent Office | 2624818 | ⤷ Try a Trial | |||
World Intellectual Property Organization (WIPO) | 2012047845 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |